GlassScriptPhysician profile
Matt Peter Marinkovich
NPI 1386734937
$77,056.29
in general payments reported to CMS, 2019-2025
8 companies · $20K in 2025
The $20K reported for 2025 was more than what 94% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $6,660 · 2022: $12K · 2023: $23K · 2024: $16K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $37K · Consulting Fee: $10K · Travel and Lodging: $6,029 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,278 · Food and Beverage: $1,222 · Education: $15.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $36,900.00 |
| Consulting Fee | $10,152.00 |
| Travel and Lodging | $6,028.79 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,278.00 |
| Food and Beverage | $1,221.91 |
| Education | $15.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Krystal Biotech INC | $42,729.06 | 2023-2025 | Vyjuvek |
| Amryt Pharma Holdings LTD | $14,619.57 | 2021-2023 | |
| Regeneron Pharmaceuticals, INC. | $10,579.79 | 2024-2025 | Dupixent |
| Argenx US, INC. | $5,612.60 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $1,530.00 | 2022-2024 | Sotyktu |
| Almirall LLC | $1,370.00 | 2021-2023 | |
| Grifols, S.A. | $600.00 | 2021 | |
| Pfizer INC. | $15.27 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matt Marinkovich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.